Collectively, these studies with both transgenic and xenograft mouse models support our earlier conclusions from in vitro studies on human cells that erlotinib augments the concentration of Bim in lung adenocarcinomas dependent upon mutant EGFR for survival. The gene discussed is BCL2L11; the disease is lung adenocarcinoma.